ADRB2 and osteoporosis: Moreover, pharmacologically blocking β2-AR with specific beta-blockers offers a strategy to mimic the high bone mass phenotype observed in β2-AR-deficient mice, potentially leading to a novel anabolic therapy for osteoporosis.